Combinations of SAP depleting agents and anti-SAP antibodies
US9192668B2 · kind B2 · utility
0Cited by
2References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 29, 2010 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Aug 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes the use of an antibody specific for serum amyloid P component, for the treatment or prophylaxis of amyloidosis, and the use of a compound which depletes serum amyloid P component from the circulation in combination with an antibody specific for serum amyloid P component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.